Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias P Wymann

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Chimia|December 18, 2021
Targeting Phosphoinositide 3-Kinase - Five Decades of Chemical Space ExplorationChiara Borsari, Matthias P Wymann
Nature Reviews. Molecular Cell Biology|January 25, 2008
Lipid signalling in diseaseMatthias P Wymann, Roger Schneiter
Nature|September 14, 2022
Two-drug trick to target the brain blocks toxicity in the bodyMatthias P Wymann, Chiara Borsari
Chembiochem : a European Journal of Chemical Biology|September 12, 2012
The chemical biology of phosphoinositide 3-kinasesMatthias P Wymann, Carsten Schultz
Current Opinion in Cell Biology|March 23, 2005
Phosphoinositide 3-kinase in disease: timing, location, and scaffoldingMatthias P Wymann, Romina Marone
Annals of the New York Academy of Sciences|April 5, 2013
Inhibition of phosphoinositide 3-kinase γ attenuates inflammation, obesity, and cardiovascular risk factorsMatthias P Wymann, Giovanni Solinas
The FEBS Journal|May 8, 2013
Membrane dynamics in physiology and diseaseMatthias P Wymann, Kai Simons
Nature Methods|March 2, 2011
Neutral not a loss: phosphoinositides beyond the head groupMatthias P Wymann, Markus R Wenk
Trends in Pharmacological Sciences|July 23, 2003
Phosphoinositide 3-kinase signalling--which way to target?Matthias P Wymann, Marketa Zvelebil, Muriel Laffargue
Chemmedchem|June 11, 2021
Chemical and Structural Strategies to Selectively Target mTOR KinaseChiara Borsari, Martina De Pascale, Matthias P Wymann
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Chimia|December 18, 2021
Targeting Phosphoinositide 3-Kinase - Five Decades of Chemical Space ExplorationChiara Borsari, Matthias P Wymann
Nature Reviews. Molecular Cell Biology|January 25, 2008
Lipid signalling in diseaseMatthias P Wymann, Roger Schneiter
Nature|September 14, 2022
Two-drug trick to target the brain blocks toxicity in the bodyMatthias P Wymann, Chiara Borsari
Chembiochem : a European Journal of Chemical Biology|September 12, 2012
The chemical biology of phosphoinositide 3-kinasesMatthias P Wymann, Carsten Schultz
Current Opinion in Cell Biology|March 23, 2005
Phosphoinositide 3-kinase in disease: timing, location, and scaffoldingMatthias P Wymann, Romina Marone
Annals of the New York Academy of Sciences|April 5, 2013
Inhibition of phosphoinositide 3-kinase γ attenuates inflammation, obesity, and cardiovascular risk factorsMatthias P Wymann, Giovanni Solinas
The FEBS Journal|May 8, 2013
Membrane dynamics in physiology and diseaseMatthias P Wymann, Kai Simons
Nature Methods|March 2, 2011
Neutral not a loss: phosphoinositides beyond the head groupMatthias P Wymann, Markus R Wenk
Trends in Pharmacological Sciences|July 23, 2003
Phosphoinositide 3-kinase signalling--which way to target?Matthias P Wymann, Marketa Zvelebil, Muriel Laffargue
Chemmedchem|June 11, 2021
Chemical and Structural Strategies to Selectively Target mTOR KinaseChiara Borsari, Martina De Pascale, Matthias P Wymann
Pageof 8